Miahelsa Holdings (TSE:7129) Research & Development: 円0 Mil (TTM As of Mar. 2026)


TSE:7129 Miahelsa Holdings Corp TSE:7129
44 GF Score
Price 円1,147.00
GF Value 円1,071.08
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Miahelsa Holdings Research & Development?

Miahelsa Holdings TSE:7129 -0.69% 44 Research & Development is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:7129 with a GF Score™ of 44/100 and a GF Value™ of 円1,071.08 (Fairly Valued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Miahelsa Holdings's Research & Development for the six months ended in Mar. 2026 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil.

Miahelsa Holdings  (TSE:7129) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Miahelsa Holdings Research & Development Related Terms

Miahelsa Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Miahelsa Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Miahelsa Holdings Research & Development Chart

Miahelsa Holdings Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
0.00 0.00 0.00 0.00 0.00

Miahelsa Holdings Semi-Annual Data
Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:7129
44GF Score
Miahelsa Holdings Corp TSE:7129
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Miahelsa Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Miahelsa Holdings (TSE:7129) has a Research & Development of 円0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Miahelsa Holdings and its competitors.
Is Miahelsa Holdings' Research & Development too high?
Miahelsa Holdings' current Research & Development is 円0 Mil. Overall, Miahelsa Holdings has a GF Score™ of 44/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Miahelsa Holdings' Research & Development compare to competitors?
Miahelsa Holdings' Research & Development of 円0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Miahelsa Holdings and its competitors. Miahelsa Holdings's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Miahelsa Holdings stock overvalued right now?
Based on GuruFocus' analysis, Miahelsa Holdings (TSE:7129) is currently considered Fairly Valued. The stock's GF Value™ is 円1,071.08, compared to a current price of 円1,147.00 — trading 7.1% above its estimated fair value. The current Research & Development is 円0 Mil. Miahelsa Holdings' overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Miahelsa Holdings (TSE:7129), the current Research & Development is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Miahelsa Holdings (TSE:7129) Overvalued in 2026?

Based on GuruFocus' analysis, Miahelsa Holdings stock appears to be overvalued. The current stock price of 円1,147.00 is trading 7.1% above its estimated GF Value™ of 円1,071.08. GuruFocus considers Miahelsa Holdings to be Fairly Valued.

Key valuation signals for TSE:7129:

  • Research & Development: 円0 Mil
  • GF Value™: 円1,071.08 vs. price of 円1,147.00 (7.1% above fair value)
  • GF Score™: 44/100 with 3 warning signs

No single metric tells the full story. See the TSE:7129 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Miahelsa Holdings Business Description

Address Ichigaya Nakano-cho 3-19, Shinjuku-ku, Tokyo, JPN, 162-0064
Miahelsa Holdings Corp, along with its subsidiaries, operates in the following reportable segments: Pharmaceutical Business, Nursing Care Business, and Childcare Business. The majority of its revenue is generated from the Pharmaceuticals Business, which operates pharmaceutical dispensaries in Japan through Nissei Pharmacy and Miahelsa Pharmacy brands, and also offers home care services. The Nursing care business mainly provides housing, medical care, nursing care, prevention, and lifestyle support for elderly people, and the Childcare segment involves the operation of licensed childcare centers. In addition, the group also operates a food business providing food suitable for all ages, from infants to the elderly.
44GF Score

Get the complete analysis for TSE:7129

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,147.00
Price
円1,071.08
GF Value